NF-κB Regulates Mesenchymal Transition for the Induction of Non-Small Cell Lung Cancer Initiating Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kumar, Manish ^a   Allison, David F ^a   Baranova, Natalya N ^a   Wamsley, J Jacob ^a   Katz, Adam J ^b   Bekiranov, Stefan ^a   Jones, David R ^a   Mayo, Marty W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST1; TRANSCRIPTION FACTOR ZEB2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INITIATING CELL; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; KLF4 GENE; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; ONCOGENE C KIT; ONCOGENE MYC; PLEIOTROPY; POU5F1 GENE; PROTEIN DEPLETION; PROTEIN EXPRESSION; SNAI1 GENE; SNAI2 GENE; SOX2 GENE; TRANSCRIPTION REGULATION; TUMOR INVASION; TWIST1 GENE; UPREGULATION; ZEB2 GENE; ANIMAL; CANCER STEM CELL; CELL TRANSFORMATION; CULTURE TECHNIQUE; DISEASE MODEL; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; MULTICELLULAR SPHEROID; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHENOTYPE; TUMOR CELL CULTURE; TUMOR CELL LINE;

CELL ADHESION MOLECULES; COLD TEMPERATURE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PHENOTYPE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84880989513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068597     Document Type: Article

References (60)

1. Cirri P, Chiarugi P, (2012) Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev 31: 195-208 10.1007/s10555-011-9340-x.
2. Korkaya H, Liu S, Wicha MS, (2011) Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 121: 3804-3809 10.1172/JCI57099.
3. Fuxe J, Karlsson MC, (2012) TGF-beta-induced epithelial-mesenchymal transition: A link between cancer and inflammation. Semin Cancer Biol 22: 455-461 10.1016/j.semcancer.2012.05.004.
4. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
5. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14: 818-829 10.1016/j.devcel.2008.05.009.
6. Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C, (2011) Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: Distinct, overlapping or same populations. Oncogene 30: 4609-4621 10.1038/onc.2011.184.
7. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
8. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888 10.1371/journal.pone.0002888.
9. Scheel C, Weinberg RA, (2011) Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer 129: 2310-2314 10.1002/ijc.26311.
10. Heldin CH, Vanlandewijck M, Moustakas A, (2012) Regulation of EMT by TGFbeta in cancer. FEBS Lett 586: 1959-1970 10.1016/j.febslet.2012.02.037.
11. Wendt MK, Tian M, Schiemann WP, (2012) Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res 347: 85-101 10.1007/s00441-011-1199-1.
12. Xu J, Lamouille S, Derynck R, (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172 10.1038/cr.2009.5.
13. Zu X, Zhang Q, Cao R, Liu J, Zhong J, et al. (2012) Transforming growth factor-beta signaling in tumor initiation, progression and therapy in breast cancer: An update. Cell Tissue Res 347: 73-84 10.1007/s00441-011-1225-3.
14. Bates RC, Mercurio AM, (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14: 1790-1800 10.1091/mbc.E02-09-0583.
15. Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, et al. (2012) TGF-beta-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J Biochem 151: 205-216 10.1093/jb/mvr136.
16. Gao D, Vahdat LT, Wong S, Chang JC, Mittal V, (2012) Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 72: 4883-4889 10.1158/0008-5472.CAN-12-1223.
17. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, et al. (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940 10.1016/j.cell.2011.04.029.
18. Basseres DS, Baldwin AS, (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830 10.1038/sj.onc.1209942.
19. Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12: 715-723 10.1038/ni.2060.
20. Shostak K, Chariot A, (2011) NF-kappaB, stem cells and breast cancer: The links get stronger. Breast Cancer Res 13: 214 10.1186/bcr2886.
21. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, et al. (2004) Regulation of snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345-7354 10.1038/sj.onc.1207990.
22. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, et al. (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724 10.1038/sj.onc.1209808.
23. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, et al. (2007) Activation of NF-kappaB by akt upregulates snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456 10.1038/sj.onc.1210546.
24. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, et al. (2007) Upregulation of twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27: 3920-3935 10.1128/MCB.01219-06.
25. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, et al. (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: 416-428 10.1016/j.ccr.2009.03.016.
26. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
27. Hoberg JE, Popko AE, Ramsey CS, Mayo MW, (2006) IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457-471.
28. Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, et al. (2012) Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription. Proc Natl Acad Sci U S A 109: 16888-16893 10.1073/pnas.1208468109.
29. Hoberg JE, Yeung F, Mayo MW, (2004) SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol Cell 16: 245-255.
30. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, et al. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380.
31. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, et al. (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581.
32. Akunuru S, James Zhai Q, Zheng Y, (2012) Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis 3: e352 10.1038/cddis.2012.93.
33. Ho MM, Ng AV, Lam S, Hung JY, (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833 10.1158/0008-5472.CAN-06-3557.
34. Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, et al. (2010) Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5: e14062 10.1371/journal.pone.0014062.
35. Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, et al. (2008) Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 371: 163-167 10.1016/j.bbrc.2008.04.038.
36. Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK, (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83: 173-180 10.1002/bit.10655.
37. Gilbert MT, Haselkorn T, Bunce M, Sanchez JJ, Lucas SB, et al. (2007) The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One 2: e537 10.1371/journal.pone.0000537.
38. Nitz MD, Harding MA, Theodorescu D, (2008) Invasion and metastasis models for studying RhoGDI2 in bladder cancer. Methods Enzymol 439: 219-233 10.1016/S0076-6879(07)00417-X.
39. Thulke S, Radonic A, Siegert W, Nitsche A, (2003) Highly sensitive quantification of human cells in chimeric NOD/SCID mice by real-time PCR. Haematologica 88: ELT18.
40. Mayo MW, Norris JL, Baldwin AS, (2001) Ras regulation of NF-kappa B and apoptosis. Methods Enzymol 333: 73-87.
41. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, et al. (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res 62: 4478-4483.
42. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
43. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, et al. (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637 10.1371/journal.pone.0002637.
44. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365 10.1038/onc.2011.338.
45. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, et al. (2010) Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70: 338-346 10.1158/0008-5472.CAN-09-1102.
46. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872 10.1016/j.cell.2007.11.019.
47. Yu F, Li J, Chen H, Fu J, Ray S, et al. (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30: 2161-2172 10.1038/onc.2010.591.
48. Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, et al. (2012) EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 11: 73-4598-11-73 10.1186/1476-4598-11-73.
49. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
50. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, et al. (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic ras. Science 278: 1812-1815.
51. Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, et al. (2011) Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-365 10.1016/j.stem.2011.08.010.
52. Kunz-Schughart LA, Kreutz M, Knuechel R, (1998) Multicellular spheroids: A three-dimensional in vitro culture system to study tumour biology. Int J Exp Pathol 79: 1-23.
53. Li Q, Chen C, Kapadia A, Zhou Q, Harper MK, et al. (2011) 3D models of epithelial-mesenchymal transition in breast cancer metastasis: High-throughput screening assay development, validation, and pilot screen. J Biomol Screen 16: 141-154 10.1177/1087057110392995.
54. Pampaloni F, Reynaud EG, Stelzer EH, (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839-845 10.1038/nrm2236.
55. Xie G, Yao Q, Liu Y, Du S, Liu A, et al. (2012) IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int J Oncol 40: 1171-1179 10.3892/ijo.2011.1275.
56. Iliopoulos D, Hirsch HA, Struhl K, (2009) An epigenetic switch involving NF-kappaB, Lin28, let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706 10.1016/j.cell.2009.10.014.
57. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, et al. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120: 485-497 10.1172/JCI39397.
58. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
59. Rokavec M, Wu W, Luo JL, (2012) IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 45: 777-789 10.1016/j.molcel.2012.01.015.
60. Baird AM, Gray SG, O'Byrne KJ, (2011) Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS One 6: e14593 10.1371/journal.pone.0014593.